Stock Track | 3SBIO Plummets 13.14% Intraday Amid Broader Biotech Selloff as Geopolitical Tensions and Oil Prices Dampen Rate Cut Hopes

Stock Track04-23

3SBIO (01530) experienced a sharp intraday decline of 13.14%, reflecting a broader downturn in the innovative drug sector during the trading session.

The selloff was driven by persistent geopolitical uncertainties and rising oil prices, which have boosted inflation expectations and subsequently limited the potential for interest rate cuts. A report highlighted that global innovative drug financing declined by 7.1% year-on-year in 2025, influenced by these global pressures and the pace of U.S. Federal Reserve monetary policy adjustments.

While the report noted a potential recovery in financing volume and suggested that a subsiding U.S.-Iran conflict coupled with continued Fed rate cuts could support a rebound in 2026, the immediate market sentiment weighed heavily on biopharma stocks like 3SBIO during the session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1183896738?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 14:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183896738","market":"hk","top_or_hot":-1,"title":"Stock Track | 3SBIO Plummets 13.14% Intraday Amid Broader Biotech Selloff as Geopolitical Tensions and Oil Prices Dampen Rate Cut Hopes","media":"Stock Track","content":"<p>3SBIO (01530) experienced a sharp intraday decline of 13.14%, reflecting a broader downturn in the innovative drug sector during the trading session.</p><p>The selloff was driven by persistent geopolitical uncertainties and rising oil prices, which have boosted inflation expectations and subsequently limited the potential for interest rate cuts. A report highlighted that global innovative drug financing declined by 7.1% year-on-year in 2025, influenced by these global pressures and the pace of U.S. Federal Reserve monetary policy adjustments.</p><p>While the report noted a potential recovery in financing volume and suggested that a subsiding U.S.-Iran conflict coupled with continued Fed rate cuts could support a rebound in 2026, the immediate market sentiment weighed heavily on biopharma stocks like 3SBIO during the session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | 3SBIO Plummets 13.14% Intraday Amid Broader Biotech Selloff as Geopolitical Tensions and Oil Prices Dampen Rate Cut Hopes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | 3SBIO Plummets 13.14% Intraday Amid Broader Biotech Selloff as Geopolitical Tensions and Oil Prices Dampen Rate Cut Hopes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-23 14:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>3SBIO (01530) experienced a sharp intraday decline of 13.14%, reflecting a broader downturn in the innovative drug sector during the trading session.</p><p>The selloff was driven by persistent geopolitical uncertainties and rising oil prices, which have boosted inflation expectations and subsequently limited the potential for interest rate cuts. A report highlighted that global innovative drug financing declined by 7.1% year-on-year in 2025, influenced by these global pressures and the pace of U.S. Federal Reserve monetary policy adjustments.</p><p>While the report noted a potential recovery in financing volume and suggested that a subsiding U.S.-Iran conflict coupled with continued Fed rate cuts could support a rebound in 2026, the immediate market sentiment weighed heavily on biopharma stocks like 3SBIO during the session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01530","symbol_name":"三生制药","start_time":0,"source_url":"","article_id":"1183896738","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183896738","pubTimestamp":1776924291,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"3SBIO (01530) experienced a sharp intraday decline of 13.14%, reflecting a broader downturn in the innovative drug sector during the trading session.The selloff was driven by persistent geopolitical...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01530":"三生制药"},"translate_title":"个股追踪|地缘政治紧张局势和油价打击降息希望，生物科技遭更广泛抛售，三生制药盘中暴跌13.14%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01530":1},"content_text":"3SBIO (01530) experienced a sharp intraday decline of 13.14%, reflecting a broader downturn in the innovative drug sector during the trading session.The selloff was driven by persistent geopolitical uncertainties and rising oil prices, which have boosted inflation expectations and subsequently limited the potential for interest rate cuts. A report highlighted that global innovative drug financing declined by 7.1% year-on-year in 2025, influenced by these global pressures and the pace of U.S. Federal Reserve monetary policy adjustments.While the report noted a potential recovery in financing volume and suggested that a subsiding U.S.-Iran conflict coupled with continued Fed rate cuts could support a rebound in 2026, the immediate market sentiment weighed heavily on biopharma stocks like 3SBIO during the session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1183896738","isCrawlerRequest":true}